Ichnos Glenmark Innovation (IGI) Announces Appointment of Mariana Cota Stirner, M.D., Ph.D., as Chief Medical Officer

▤ Summary

IGI has appointed Mariana Cota Stirner, M.D., Ph.D., as Chief Medical Officer. She brings more than 20 years of oncology and hematology development experience, including leadership roles at AbbVie, Bristol Myers Squibb, Novartis, and Nuvisan. Her background includes managing Phase I–III oncology trials and helping secure multiple global regulatory approvals. The appointment supports IGI’s effort to advance its multispecific oncology pipeline and move its first-in-class immune cell activator closer to the clinic.

▦ Linked Companies